4.8 Article

An Iron(III)-Based Metal-Organic Gel-Catalyzed Dual Electrochemiluminescence System for Cytosensing and In Situ Evaluation of the VEGF165 Subtype

Journal

ANALYTICAL CHEMISTRY
Volume 94, Issue 9, Pages 4095-4102

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c00032

Keywords

-

Funding

  1. National Natural Science Foundation of China [22176086]
  2. Natural Science Foundation of Jiangsu Province [BK20210189]
  3. State Key Laboratory of Pollution Control and Resource Reuse [PCRR-ZZ-202106]
  4. China Postdoctoral Science Foundation [2021T140306]

Ask authors/readers for more resources

This study utilizes Fe(III)-organic gel as an electrode matrix to enhance the electrochemiluminescence (ECL) emission by producing reactive oxygen species. By employing a ratiometric strategy and cooperative signals, accurate cytosensing and subtype evaluation of VEGF(165) were achieved. This research not only expands the application of MOGs as effective catalyst matrices but also provides reliable cell assays and protein subtype identification for clinical diagnosis and research.
The recent surge of interest in metal-organic gels (MOGs) has emerged for their soft porous structure, large surface area, and abundant active metal sites, making them a promising candidate for building catalyst matrices. In this work, facilely synthesized Fe(III)-organic gel was directly used as a robust electrode matrix. Detailed studies illustrated that their Fe(III) centers can speed up the electro-oxidation/reduction of the H2O2 coreactant to produce reactive oxygen species for enhancing a potential-resolved dual electrochemiluminescence (ECL) emission. Among them, the anodic signal of luminol varied with the cell concentration based on the impedance ECL mechanism, while the cathodic signal of CdS quantum dots traced the VEGF(165) subtype at cell surface by specific aptamer recognition. Based on this, a ratiometric strategy was proposed for accurate cytosensing by eliminating environmental interference. Moreover, by cooperating these two signals, a novel strategy was developed for direct evaluation of the VEGF(165) subtype, further realizing rapid drug screening and subtype assessment on different cell lines. This work not only opens up the promising application of MOGs as an effective catalyst matrix but also develops reliable cell assays and protein subtype identification for clinical diagnosis and research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available